<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01723852</url>
  </required_header>
  <id_info>
    <org_study_id>VIDI-2012-01</org_study_id>
    <nct_id>NCT01723852</nct_id>
  </id_info>
  <brief_title>Vitamin D Intervention in Infants</brief_title>
  <acronym>VIDI</acronym>
  <official_title>Vitamin D Intervention in Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Finnish Governmental Special Subsidy for Health Sciences Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Päivikki and Sakari Sohlberg Foundation, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finska Läkaresällskapet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomized, controlled, double blinded study evaluating the effect of
      recommended (400 IU) and 1 200 IU daily vitamin D substitution, given from 2 weeks to 2 years
      of age, on growth, bone development, neurologic and cognitive development, frequence of
      infectious diseases, allergic symptoms, and development of immunoregulation assessed at 2
      years of age.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2013</start_date>
  <completion_date type="Actual">November 20, 2017</completion_date>
  <primary_completion_date type="Actual">July 15, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Growth</measure>
    <time_frame>2 years of age</time_frame>
    <description>Measurement of growth at 2 years of age</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurologic and cognitive development</measure>
    <time_frame>At 2 years of age</time_frame>
    <description>By means of questionnaires and, on a randomly selected group of study subjects, cognitive function testing to assess neurologic and cognitive development</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of allergic symptoms and infection</measure>
    <time_frame>At 2 years of age</time_frame>
    <description>Assessment of the frequency of allergic symptoms and infections by means of questionnaires, hospital discharge records and prescription data.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Development of immunoregulation</measure>
    <time_frame>At 2 years of age</time_frame>
    <description>Assessment of the tolerogenic properties of T-cells and dendritic cell function from blood sample in a subgroup of 100 study subjects.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>2 years of age</time_frame>
    <description>Bone mineral density is measured by dual energy x-ray absorptiometry and peripheral quantitative computerized tomography</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Vitamin D Status</condition>
  <arm_group>
    <arm_group_label>Vitamin D supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin D supplement according to national guidelines (10 ug/day) from 2 weeks to 2 years of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D supplement at 30 ug/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin D supplement at 30 ug/day from 2 weeks to 2 years of age</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D at 30 ug/day</intervention_name>
    <arm_group_label>Vitamin D supplement at 30 ug/day</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D at 10 ug/day</intervention_name>
    <arm_group_label>Vitamin D supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants born at term (37-42 wks, weight appropriate for gestational age) are included
             in the study

        Exclusion Criteria:

          -  Non Caucasian mother

          -  Any continuous regular medication of mother

          -  Treatment at neonatal intensive care unit

          -  Antibiotic treatment of the infant

          -  Congenital malformations of the newborn

          -  Treatment with ventilation support (continuous nasal positive airway pressure) for
             over 24 hours

          -  Glucose infusion of the newborn

          -  Neurological symptoms of the newborn

          -  Phototherapy for jaundice of the newborn

          -  Need for nasogastric feeding of the newborn
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sture Andersson, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital, Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kätilöopisto Maternity Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <link>
    <url>http://www.d-vitamiinitutkimus.info</url>
    <description>Study web-page in Finnish</description>
  </link>
  <reference>
    <citation>Holmlund-Suila E, Viljakainen H, Hytinantti T, Lamberg-Allardt C, Andersson S, Mäkitie O. High-dose vitamin d intervention in infants--effects on vitamin d status, calcium homeostasis, and bone strength. J Clin Endocrinol Metab. 2012 Nov;97(11):4139-47. doi: 10.1210/jc.2012-1575. Epub 2012 Aug 29.</citation>
    <PMID>22933541</PMID>
  </reference>
  <reference>
    <citation>Helve O, Viljakainen H, Holmlund-Suila E, Rosendahl J, Hauta-Alus H, Enlund-Cerullo M, Valkama S, Heinonen K, Räikkönen K, Hytinantti T, Mäkitie O, Andersson S. Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI) - study design and methods of a randomised controlled double-blinded intervention study. BMC Pediatr. 2017 Mar 29;17(1):91. doi: 10.1186/s12887-017-0845-5.</citation>
    <PMID>28356142</PMID>
  </reference>
  <results_reference>
    <citation>Rosendahl J, Holmlund-Suila E, Helve O, Viljakainen H, Hauta-Alus H, Valkama S, Enlund-Cerullo M, Hytinantti T, Tervahartiala T, Sorsa T, Mäkitie O, Andersson S. 25-hydroxyvitamin D correlates with inflammatory markers in cord blood of healthy newborns. Pediatr Res. 2017 May;81(5):731-735. doi: 10.1038/pr.2017.9. Epub 2017 Jan 13.</citation>
    <PMID>28085793</PMID>
  </results_reference>
  <results_reference>
    <citation>Hauta-Alus HH, Holmlund-Suila EM, Rita HJ, Enlund-Cerullo M, Rosendahl J, Valkama SM, Helve OM, Hytinantti TK, Surcel HM, Mäkitie OM, Andersson S, Viljakainen HT. Season, dietary factors, and physical activity modify 25-hydroxyvitamin D concentration during pregnancy. Eur J Nutr. 2017 Mar 2. doi: 10.1007/s00394-017-1417-z. [Epub ahead of print]</citation>
    <PMID>28255653</PMID>
  </results_reference>
  <results_reference>
    <citation>Valkama S, Holmlund-Suila E, Enlund-Cerullo M, Rosendahl J, Hauta-Alus H, Helve O, Hytinantti T, Viljakainen H, Andersson S, Mäkitie O. No Severe Hypercalcemia with Daily Vitamin D3 Supplementation of up to 30 µg during the First Year of Life. Horm Res Paediatr. 2017;88(2):147-154. doi: 10.1159/000477298. Epub 2017 Jun 23.</citation>
    <PMID>28647736</PMID>
  </results_reference>
  <results_reference>
    <citation>Holmlund-Suila E, Enlund-Cerullo M, Valkama S, Hauta-Alus H, Rosendahl J, Helve O, Hytinantti T, Viljakainen H, Andersson S, Mäkitie O. Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4526-4533. doi: 10.1210/jc.2017-01211.</citation>
    <PMID>29029193</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2012</study_first_submitted>
  <study_first_submitted_qc>November 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2012</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Sture Andersson</investigator_full_name>
    <investigator_title>Professor of Neonatology</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Infectious diseases</keyword>
  <keyword>cognitive development</keyword>
  <keyword>Bone mineral density</keyword>
  <keyword>Immunoregulation</keyword>
  <keyword>Allergy</keyword>
  <keyword>Growth</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

